Magnetic Resonance - Technology Information Portal Welcome to MRI Technology••


Dear Guest, Your Attention Please:  

In the next days, the daily page limit for non-members will decrease to 20 pages to split up resources in favour of the MR-TIP Community. Beyond this limitation, most resources will still be available for everyone. If you want to join the MR-TIP Community, please register here.

 'Intracellular Contrast Agents' 
  2 3 5 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Result : Searchterm 'Intracellular Contrast Agents' found in 1 term [] and 3 definitions []
1 - 4 (of 4)     
Result Pages : [1]
MRI Resources 
Hospitals - Health - Artifacts - Blood Flow Imaging - Knee MRI - Pathology
Intracellular Contrast AgentsInfoSheet: - Contrast Agents - 
Intro, Overview, 
Types of, 
etc.MRI Resource Directory:
 - Contrast Agents -
Contrast agent with a preferential intracellular distribution.
Intracellular agents (such as manganese derivatives and ultrasmall superparamagnetic iron oxide), exhibit a flow- and metabolism-dependent uptake. These properties may allow delayed imaging, similar to isotopic methods.
Phospholipid liposomes are rapidly sequestered by the cells in the reticuloendothelial system (RES), primarily in the liver. For imaging of the liver, liposomes may be labeled with MR contrast medium, both positive (T1-shortening) paramagnetic media, and negative (T2-shortening) superparamagnetic media.
Several other nonliposome MR contrast media are also taken up by the RES, e.g.:
superparamagnetic iron oxide (SPIO)
ultrasmall superparamagnetic iron oxide (USPIO)
monocrystalline iron oxide nanoparticle (MION)

Other MR contrast agents accumulate selectively in the hepatocytes, e.g.:
gadoxetic acid (Gd-EOB-DTPA)
gadobenate dimeglumine (Gd-BOPTA)
mangafodipir trisodium (Mn-DPDP)
• Share the entry 'Intracellular Contrast Agents':  Facebook  Twitter  LinkedIn  
MRI Resources 
Blood Flow Imaging - Resources - Anatomy - Mass Spectrometry - Functional MRI - Process Analysis
Liver ImagingForum -
related threadsMRI Resource Directory:
 - Liver Imaging -
Liver imaging can be performed with sonography, computed tomography (CT) and magnetic resonance imaging (MRI). Ultrasound is, caused by the easy access, still the first-line imaging method of choice; CT and MRI are applied whenever ultrasound imaging yields vague results. Indications are the characterization of metastases and primary liver tumors e.g., benign lesions such as focal nodular hyperplasia (FNH), adenoma, hemangioma and malignant lesions (cancer) such as hepatocellular carcinomas (HCC). The decision, which medical imaging modality is more suitable, MRI or CT, is dependent on the different factors. CT is less costly and more widely available; modern multislice scanners provide high spatial resolution and short scan times but has the disadvantage of radiation exposure.
With the introduction of high performance MR systems and advanced sequences the image quality of MRI for the liver has gained substantially. Fast spin echo or single shot techniques, often combined with fat suppression, are the most common T2 weighted sequences used in liver MRI procedures. Spoiled gradient echo sequences are used as ideal T1 weighted sequences for evaluating of the liver. The repetition time (TR) can be sufficiently long to acquire enough sections covering the entire liver in one pass, and to provide good signal to noise. The TE should be the shortest in phase echo time (TE), which provides strong T1 weighting, minimizes magnetic susceptibility effects, and permits acquisition within one breath hold to cover the whole liver. A flip angle of 80° provides good T1 weighting and less of power deposition and tissue saturation than a larger flip angle that would provide comparable T1 weighting.
Liver MRI is very dependent on the administration of contrast agents, especially when detection and characterization of focal lesions are the issues. Liver MRI combined with MRCP is useful to evaluate patients with hepatic and biliary disease.
Gadolinium chelates are typical non-specific extracellular agents diffusing rapidly to the extravascular space of tissues being cleared by glomerular filtration at the kidney. These characteristics are somewhat problematic when a large organ with a huge interstitial space like the liver is imaged. These agents provide a small temporal imaging window (seconds), after which they begin to diffuse to the interstitial space not only of healthy liver cells but also of lesions, reducing the contrast gradient necessary for easy lesion detection. Dynamic MRI with multiple phases after i.v. contrast media (Gd chelates), with arterial, portal and late phase images (similar to CT) provides additional information.
An additional advantage of MRI is the availability of liver-specific contrast agents (see also Hepatobiliary Contrast Agents). Gd-EOB-DTPA (gadoxetate disodium, Gadolinium ethoxybenzyl dimeglumine, EOVIST Injection, brand name in other countries is Primovist) is a gadolinium-based MRI contrast agent approved by the FDA for the detection and characterization of known or suspected focal liver lesions.
Gd-EOB-DTPA provides dynamic phases after intravenous injection, similarly to non-specific gadolinium chelates, and distributes into the hepatocytes and bile ducts during the hepatobiliary phase. It has up to 50% hepatobiliary excretion in the normal liver.
Since ferumoxides are not eliminated by the kidney, they possess long plasmatic half-lives, allowing circulation for several minutes in the vascular space. The uptake process is dependent on the total size of the particle being quicker for larger particles with a size of the range of 150 nm (called superparamagnetic iron oxide). The smaller ones, possessing a total particle size in the order of 30 nm, are called ultrasmall superparamagnetic iron oxide particles and they suffer a slower uptake by RES cells. Intracellular contrast agents used in liver MRI are primarily targeted to the normal liver parenchyma and not to pathological cells. Currently, iron oxide based MRI contrast agents are not marketed.
Beyond contrast enhanced MRI, the detection of fatty liver disease and iron overload has clinical significance due to the potential for evolution into cirrhosis and hepatocellular carcinoma. Imaging-based liver fat quantification (see also Dixon) provides noninvasively information about fat metabolism; chemical shift imaging or T2*-weighted imaging allow the quantification of hepatic iron concentration. See also Abdominal Imaging, Primovist™, Liver Acquisition with Volume Acquisition (LAVA), T1W High Resolution Isotropic Volume Examination (THRIVE) and Bolus Injection.

For Ultrasound Imaging (USI) see Liver Sonography at
Images, Movies, Sliders:
 Anatomic Imaging of the Liver  Open this link in a new window

 MRI Liver T2 TSE  Open this link in a new window
Radiology-tip.comAbdomen CT,  Biliary Contrast Agents
Radiology-tip.comLiver Sonography,  Vascular Ultrasound Contrast Agents

• View the DATABASE results for 'Liver Imaging' (13).Open this link in a new window

• View the NEWS results for 'Liver Imaging' (10).Open this link in a new window.
Further Reading:
Contrast MRI Best at Finding Liver Trouble - But Timing Matters
Sunday, 6 March 2011   by    
MR contrast agents: Applications in hepatobiliary imaging
Thursday, 11 November 2010   by    
Elastography: A Useful Method in Depicting Liver Hardness
Thursday, 15 April 2010   by    
Iron overload: accuracy of in-phase and out-of-phase MRI as a quick method to evaluate liver iron load in haematological malignancies and chronic liver disease
Friday, 1 June 2012   by    
  News & More:
EMA's final opinion confirms restrictions on use of linear gadolinium agents in body scans
Friday, 21 July 2017   by    
MRI-PDFF images successfully measure liver fat content
Tuesday, 28 February 2017   by    
EORTC study aims to qualify ADC as predictive imaging biomarker in preoperative regimens
Monday, 4 January 2016   by    
MRI effectively measures hemochromatosis iron burden
Saturday, 3 October 2015   by    
Perspectum Diagnostics Announces FDA Clearance for LiverMultiscan MR Imaging Device
Thursday, 12 November 2015   by    
Total body iron balance: Liver MRI better than biopsy
Sunday, 15 March 2015   by    
MRI Resources 
Databases - Equipment - Breast Implant - MRI Centers - Case Studies - Movies
Molecular Imaging
Molecular Imaging is a new diagnostic discipline to visualize biological processes.
Molecular magnetic resonance imaging (mMRI) offers the potential to image tissues at the cellular and subcellular level. Targeted MR contrast agents enhance the diagnostic specificity and range of molecular magnetic resonance imaging.
Other modalities that can be used for noninvasive molecular imaging:
optical imaging;
positron emission tomography (PET);
single photon emission computed tomography (SPECT).
See also Nanoparticle, Monocrystalline Iron Oxide Nanoparticle, Polycrystalline Iron Oxide Nanoparticles, Liposomes, Monoclonal Antibodies, Bimodal Imaging, Tumor Specific Agents, and Intracellular Contrast Agents.

• View the DATABASE results for 'Molecular Imaging' (10).Open this link in a new window

• View the NEWS results for 'Molecular Imaging' (28).Open this link in a new window.
Further Reading:
Multimodal Nanoparticles for Quantitative Imaging(.pdf)
Tuesday, 13 December 2011   by    
Molecular Magnetic Resonance Imaging(.pdf)
2005   by    
  News & More:
Smarter MRI diagnosis with nano MRI lamp
Monday, 6 February 2017   by    
Molecular MRI technique gives early indication of cancer treatment effectiveness
Monday, 11 April 2016   by    
Molecular imaging and radiochemistry: the importance of instrumentation. An interview with Professor Bjorn Wangler
Thursday, 4 February 2016   by    
Positron Emission Tomographic Imaging in Stroke
Monday, 28 December 2015   by    
Potential and Limitations of Oxygen-17 MR Perfusion Measurements
Monday, 1 March 2004   by    
MRI Resources 
NMR - Manufacturers - Non-English - MRI Reimbursement - Coils - Patient Information
Ultrasmall Superparamagnetic Iron OxideInfoSheet: - Contrast Agents - 
Intro, Overview, 
Types of, 
(USPIO) The class of the ultrasmall superparamagnetic iron oxide includes several chemically and pharmacologically very distinct materials, which may or may not be interchangeable for a specific use. Some ultrasmall SPIO particles (median diameter less than 50nm) are used as MRI contrast agents (Sinerem®, Combidex®), e.g. to differentiate metastatic from inflammatory lymph nodes. USPIO shows also potential for providing important information about angiogenesis in cancer tumors and could possibly complement MRI helping physicians to identify dangerous arteriosclerosis plaques.
Because of the disadvantageous large T2*//T1 ratio, USPIO compounds are less suitable for arterial bolus contrast enhanced magnetic resonance angiography than gadolinium complexes. The tiny ultrasmall superparamagnetic iron oxides do not accumulate in the RES system as fast as larger particles, which results in a long plasma half-life. USPIO particles, with a small median diameter (less than 10 nm), will accumulate in lymph nodes after an intravenous injection by e.g. direct transcapillary passage through endothelial venules. Once within the nodal parenchyma, phagocytic cells of the mononuclear phagocyte system take up the particles.
As a second way, USPIOs are subsequently taken up from then interstitium by lymphatic vessels and transported to regional lymph nodes. A lymph node with normal phagocytic function takes up a considerable amount and shows a reduction of the signal intensity caused by T2 shortening effects and magnetic susceptibility. Caused by the small uptake of the USPIOs in metastatic lymph nodes, they appear with less signal reduction, and permit the differentiation of healthy lymph nodes from normal-sized, metastatic nodes.
See also Superparamagnetic Contrast Agents, Superparamagnetic Iron Oxide, Very Small Superparamagnetic Iron Oxide Particles, Blood Pool Agents, Intracellular Contrast Agents.

• View the DATABASE results for 'Ultrasmall Superparamagnetic Iron Oxide' (16).Open this link in a new window

• View the NEWS results for 'Ultrasmall Superparamagnetic Iron Oxide' (2).Open this link in a new window.
Further Reading:
Comparison of Two Superparamagnetic Viral-Sized Iron Oxide Particles Ferumoxides and Ferumoxtran-10 with a Gadolinium Chelate in Imaging Intracranial Tumors
2002   by    
  News & More:
Optimized Labelling of Human Monocytes with Iron Oxide MR Contrast Agents
Sunday, 30 November 2003   by    
MRI Resources 
IR - Services and Supplies - Health - Pregnancy - Safety pool - Software
     1 - 4 (of 4)     
Result Pages : [1]
 Random Page
Share This Page

Forgot your UserID/Password ?  

The impact of TTIP/TPP on the MRI scanner market will bring :
more variety 
better scanners 
more risk 
less regulation 
cheaper scanners 
Lost in Translation 
no change at all 

      Ups uses cookies! By browsing, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • 
Copyright © 2003 - 2018 SoftWays. All rights reserved. [ 23 May 2019]
Terms of Use | Privacy Policy | Advertising
 [last update: 2018-03-08 05:11:00]